Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by OS Therapies Inc.

OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, Lung Metastatic Pediatric Osteosarcoma
From OS Therapies Inc.
Via Business Wire
Tickers OSTX
OS Therapies Reports First Quarter 2025 Financial Results and Provides Business Update
From OS Therapies Inc.
Via Business Wire
Tickers OSTX
OS Therapies Reports Full Year 2024 Financial Results and Provides Business Update
From OS Therapies Inc.
Via Business Wire
Tickers OSTX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.